TXTM
vs
S&P 500
TXTM
S&P 500
Over the past 12 months, TXTM has significantly outperformed S&P 500, delivering a return of +863% compared to the S&P 500's +17% growth.
Stocks Performance
TXTM vs S&P 500
Performance Gap
TXTM vs S&P 500
Performance By Year
TXTM vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Protext Mobility Inc
Glance View
ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. The company is headquartered in Delray Beach, Florida. The company went IPO on 2003-08-21. The firm is engaged in the research, clinical testing and commercialization of bioavailable botanical products, which includes all-natural ingredients formulated for nutraceutical and pharmaceutical applications. The firm is focused on the development of pharmaceutical applications for botanical drugs and has the license to develop Phytofare in botanical drug applications. The Phytofare is bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have greater bioavailability over generic extract. The Company’s subsidiaries include EchoMetrix, Plandai Biotechnology and Cannabis Biosciences, Inc.
